Frontiers in Medicine (Dec 2024)
Conjunctival ultraviolet autofluorescence as a biomarker of outdoor time in myopic children
- Miriam de la Puente,
- Miriam de la Puente,
- Valentina Bilbao-Malavé,
- Valentina Bilbao-Malavé,
- Jorge González-Zamora,
- Jorge González-Zamora,
- Aura Ortega Claici,
- Aura Ortega Claici,
- Jaione Bezunartea,
- Jaione Bezunartea,
- Jaione Bezunartea,
- Leire Gomez-Arteta,
- Elena Alonso,
- Elena Alonso,
- Elena Alonso,
- Elena Alonso,
- María Hernández,
- María Hernández,
- María Hernández,
- María Hernández,
- Patricia Fernández-Robredo,
- Patricia Fernández-Robredo,
- Patricia Fernández-Robredo,
- Patricia Fernández-Robredo,
- Manuel Sáenz de Viteri,
- Manuel Sáenz de Viteri,
- Manuel Sáenz de Viteri,
- Manuel Sáenz de Viteri,
- Nerea Martín Calvo,
- Nerea Martín Calvo,
- Nerea Martín Calvo,
- Alfredo García-Layana,
- Alfredo García-Layana,
- Alfredo García-Layana,
- Alfredo García-Layana,
- Jesús Barrio-Barrio,
- Jesús Barrio-Barrio,
- Jesús Barrio-Barrio,
- Jesús Barrio-Barrio,
- Sergio Recalde,
- Sergio Recalde,
- Sergio Recalde,
- Sergio Recalde
Affiliations
- Miriam de la Puente
- Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain
- Miriam de la Puente
- Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, Pamplona, Spain
- Valentina Bilbao-Malavé
- Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, Pamplona, Spain
- Valentina Bilbao-Malavé
- Department of Ophthalmology, Bellvitge University Hospital, Barcelona, Spain
- Jorge González-Zamora
- Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain
- Jorge González-Zamora
- Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, Pamplona, Spain
- Aura Ortega Claici
- Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, Pamplona, Spain
- Aura Ortega Claici
- Faculty of Medicine, Universidad de Navarra, Pamplona, Spain
- Jaione Bezunartea
- Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain
- Jaione Bezunartea
- Navarra Institute for Health Research, IdiSNA, Pamplona, Spain
- Jaione Bezunartea
- Red Temática de Investigación Cooperativa en Salud: ‘Prevention, Early Detection, and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology’ from (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Madrid, Spain
- Leire Gomez-Arteta
- Faculty of Medicine, Universidad de Navarra, Pamplona, Spain
- Elena Alonso
- Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain
- Elena Alonso
- Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, Pamplona, Spain
- Elena Alonso
- Navarra Institute for Health Research, IdiSNA, Pamplona, Spain
- Elena Alonso
- Red Temática de Investigación Cooperativa en Salud: ‘Prevention, Early Detection, and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology’ from (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Madrid, Spain
- María Hernández
- Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain
- María Hernández
- Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, Pamplona, Spain
- María Hernández
- Navarra Institute for Health Research, IdiSNA, Pamplona, Spain
- María Hernández
- Red Temática de Investigación Cooperativa en Salud: ‘Prevention, Early Detection, and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology’ from (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Madrid, Spain
- Patricia Fernández-Robredo
- Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain
- Patricia Fernández-Robredo
- Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, Pamplona, Spain
- Patricia Fernández-Robredo
- Navarra Institute for Health Research, IdiSNA, Pamplona, Spain
- Patricia Fernández-Robredo
- Red Temática de Investigación Cooperativa en Salud: ‘Prevention, Early Detection, and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology’ from (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Madrid, Spain
- Manuel Sáenz de Viteri
- Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain
- Manuel Sáenz de Viteri
- Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, Pamplona, Spain
- Manuel Sáenz de Viteri
- Navarra Institute for Health Research, IdiSNA, Pamplona, Spain
- Manuel Sáenz de Viteri
- Red Temática de Investigación Cooperativa en Salud: ‘Prevention, Early Detection, and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology’ from (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Madrid, Spain
- Nerea Martín Calvo
- Navarra Institute for Health Research, IdiSNA, Pamplona, Spain
- Nerea Martín Calvo
- School of Medicine, Department of Preventive Medicine and Public Health, University de Navarra, Pamplona, Spain
- Nerea Martín Calvo
- CIBERobn Physiopathology of Obesity and Nutrition, Carlos III Institute of Health, Madrid, Spain
- Alfredo García-Layana
- Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain
- Alfredo García-Layana
- Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, Pamplona, Spain
- Alfredo García-Layana
- Navarra Institute for Health Research, IdiSNA, Pamplona, Spain
- Alfredo García-Layana
- Red Temática de Investigación Cooperativa en Salud: ‘Prevention, Early Detection, and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology’ from (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Madrid, Spain
- Jesús Barrio-Barrio
- Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain
- Jesús Barrio-Barrio
- Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, Pamplona, Spain
- Jesús Barrio-Barrio
- Navarra Institute for Health Research, IdiSNA, Pamplona, Spain
- Jesús Barrio-Barrio
- Red Temática de Investigación Cooperativa en Salud: ‘Prevention, Early Detection, and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology’ from (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Madrid, Spain
- Sergio Recalde
- Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain
- Sergio Recalde
- Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, Pamplona, Spain
- Sergio Recalde
- Navarra Institute for Health Research, IdiSNA, Pamplona, Spain
- Sergio Recalde
- Red Temática de Investigación Cooperativa en Salud: ‘Prevention, Early Detection, and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology’ from (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Madrid, Spain
- DOI
- https://doi.org/10.3389/fmed.2024.1492180
- Journal volume & issue
-
Vol. 11
Abstract
IntroductionThe prevalence of myopia has increased significantly in recent years including an earlier onset of myopia development on the pediatric population. The main objective of the study is to compare CUVAF (Conjunctival Ultraviolet Autofluorescence) in children with and without myopia to validate its usefulness as an outdoor protective biomarker.MethodsA case–control observational study was conducted in a child cohort from subjects that attended to the Ophthalmology Department of Clínica Universidad de Navarra for an ophthalmological examination. The general exclusion criteria were (among others): amblyopia, congenital myopia, general ophthalmic disease, and any conjunctival alteration that might difficult the measurement of the CUVAF area. All participants underwent an automatic objective refraction under cycloplegic effect, biometry to measure axial length (AL) and central corneal radius (CCR), and completed a questionnaire about their lifestyle habits. A total of 4 images of the bulbar conjunctiva were taken with blue light in order to quantify the CUVAF area.ResultsA total of 263 subjects (6 to 17 years old) were analyzed with no significant differences in demographic data between case group and control group. There were 50 non-myopic subjects (19%) and 213 myopic subjects (81%). In relation to the outdoor activities (OA), myopic subjects spent significantly fewer hours per week outdoors than the control-group (p = 0.03). About the CUVAF area, the differences between groups were statistically significant, showing that the myopic group has a significantly smaller CUVAF area than the control-group (0.33 ± 0.72 mm2 vs. 0.78 ± 1.22 mm2; p = 0.0023), likewise, the frequency of CUVAF area absence between both groups showed an odds ratio (OR) of 2.52 (CI95% 1.33–4.74). A Pearson correlation test was done, obtaining a strong significant inverse correlation between myopia degree-CUVAF area (r = 0.1877; IC95% 0.068–0.302), and also ratio (AL/CCR)-CUVAF area (p = 0.002 and p = 0.04) respectively.ConclusionCUVAF is a useful biomarker for OA and it has an inverse relationship with myopia degree also in pediatric age, especially after the age of 12, so it could be useful to differentiate the risk of developing myopia. Having a CUVAF area greater than that corresponding to age, protect to myopia 2.5 times, being almost 5 times the protection in case of high myopia.
Keywords